Plenary Session (1): The Breast Cancer Landscape - What's on the Horizon? - Stephanie Goff
Stephanie Goff, MD
Associate Research Physician, National Cancer Institute, National Institutes of Health
Length - 12:48 | Email to a Colleague | Share:
Plenary Session (1): The Breast Cancer Landscape - What's on the Horizon? - Sasha Stanton
Sasha Stanton, MD, PhD
Assistant Profession, UW Medicine, Acting instructor in Breast Oncology at the University of Washington/Seattle Cancer Care Alliance
Length - 20:13 | Email to a Colleague | Share:
Plenary Session (1): The Breast Cancer Landscape - What's on the Horizon? - Nicholas P. McAndrew
Nicholas P. McAndrew, MD, MSCE
Clinical Instructor, Division of Hematology/Oncology, UCLA David Geffen School of Medicine
Length - 23:41 | Email to a Colleague | Share:
Plenary Session (1): The Breast Cancer Landscape - What's on the Horizon? - Joy Simha
Joy Simha
NBCC Board of Directors, Young Survival Coalition
Length - 11:10 | Email to a Colleague | Share:
Plenary Session (2): Conflicts of Interest and their Impact on Progress Toward Ending Breast Cancer - Aaron P. Mitchell
Aaron P. Mitchell, MD, MPH
Medical Oncologist, Memorial Sloan Kettering Cancer Center (MSK); Assistant Attending, Department of Epidemiology and Biostatistics, MSK
Length - 23:28 | Email to a Colleague | Share:
Plenary Session (2): Conflicts of Interest and their Impact on Progress Toward Ending Breast Cancer - Matthew McCoy
Matthew McCoy, PhD
Assistant Professor, Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania
Length - 21:27 | Email to a Colleague | Share:
Plenary Session (2): Conflicts of Interest and their Impact on Progress Toward Ending Breast Cancer - Judi Hirshfield-Bartek
Judi Hirshfield-Bartek
NBCC Board of Directors, Dr. Susan Love Research Foundation
Length - 19:15 | Email to a Colleague | Share:
Workshop 1 – Reading Beyond the Hype In News Media and Scientific Literature Claims Regarding Cancer Treatments
Speakers:
Gary Schwitzer, Publisher, HealthNewsReview.org, Adjunct Associate Professor, University of Minnesota School of Public Health
Moderators:
Ann Fonfa, NBCC Board of Directors, Annie Appleseed Project
Length - 1:00:36 | Email to a Colleague | Share:
Workshop 2 – Clinical Trial Design and Outcomes - Lynne Howie
Lynne Howie, MD, MA, Oncologist, formerly a Medical Officer in the Division of Oncology Products, Center for Drug Evaluation and Research at the U.S. Food and Drug Administration
Length - 24:07 | Email to a Colleague | Share:
Workshop 2 – Clinical Trial Design and Outcomes - Carol Matyka
Carol Matyka, NBCC Board of Directors, CARE Advocates Network
Length - 21:07 | Email to a Colleague | Share:
Workshop 3 – Value and Transparency in Cancer Drug Development
Speakers:
Aaron N. Winn, PhD, Assistant Professor, Pharmacy Administration, Department of Clinical Sciences, Medical College of Wisconsin
Moderator:
Beth Emery, NBCC Board of Directors Alternate; Alamo Breast Cancer Foundation
Length - 1:00:10 | Email to a Colleague | Share:
Workshop 4 – Metastatic Breast Cancer and the Tumor Microenvironment
Speaker:
Cyrus Ghajar, PhD, Director, Laboratory for the Study of Metastatic Microenvironments (LSM2), Fred Hutchinson Cancer Research Center
Moderator:
Chiara D'Agostino, NBCC Breast Cancer Advocate
Length - 56:06 | Email to a Colleague | Share:
Plenary (3): Ten Years Into the ARTEMIS Project®– What Have We Accomplished and Where Do We Go Next?
Speakers:
Cyrus Ghajar, PhD, Director, Laboratory for the Study of Metastatic Microenvironments (LSM2), Fred Hutchinson Cancer Research Center
Alana Welm, PhD, Associate Professor in the Department of Oncological Sciences at the University of Utah, an Investigator at the Huntsman Cancer Institute, and Co-Leader of the Cell Response and Regulation Program at HCI
Keith Knutson, PhD, Professor of Immunology, Department of Immunology; Director, Mayo Clinic Florida Discovery and Translation Labs, Cancer Research Program; Director, Mayo Clinic Cancer Center Immunology and Immunotherapy Program
Pat Haugen, NBCC Team Leader, MN, NBCC Breat Cancer Advocate
Moderator:
Michele Rakoff, NBCC Board of Directors, Breast Cancer Care and Research Fund
Length - 1:13:27 | Email to a Colleague | Share:
Workshop 1 - Disparities in Breast Cancer
Speakers:
Otis W. Brawley, MD, Bloomberg Distinguished Professor, Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center
Moderators:
Valencia Robinson, NBCC Breast Cancer Advocate (Session 1)
Shirley Brown, NBCC Team Leader, CA, NBCC Breast Cancer Advocate (Session 2)
Length - 52:07 | Email to a Colleague | Share:
Workshop 2 - Grassroots Advocacy - Building, Engaging and Mobilizing Your Network
Speakers:
Iowa Advocates - Lori Seawel, Kristin Teig Torres
Maine Advocates - Laurel Bezanson, Bethany Zell
Moderators:
Jerry Worden, NBCC Board of Directors, Alamo Breast Cancer Foundation (Session 1)
Valerie Fraser, NBCC Breast Cancer Advocate (Session 2)
Length - 54:32 | Email to a Colleague | Share:
Workshop 3 – Informed Consent in Clinical Research
Pat Haugen, NBCC Breast Cancer Advocate
Length - 8:07 | Email to a Colleague | Share:
Workshop 3 – Informed Consent in Clinical Research - Andrea Denicoff
Andrea Denicoff, MS, RN, Head, NCTN Clinical Trials Operations, Scientific Liaison, Patient Reported Outcomes, Clinical Investigations Branch, CTEP, DCTD, NCI
Length - 31:59 | Email to a Colleague | Share:
Workshop 4 – Vaccines for Breast Cancer – Understanding the Science
Speakers:
H. Kim Lyerly, MD, George Barth Geller Professor, Professor of Surgery, Immunology, and Pathology Duke University School of Medicine
Moderators:
Caroline Abi-Khattar, NBCC Board of Directors Alternate, Young Survival Coalition (Session 1)
Judy Perkins, NBCC Team Leader, FL, NBCC Breast Cancer Advocate (Session 2)
Length - 52:32 | Email to a Colleague | Share: